Bugsu Ovunc
Pediatric Pulmonology · Torrance, CANPI 1891086088
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,322, more than ten times the $25 reported in 2019.
Across 122 payments — averaging $26.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$539
- Amgen$488
- AstraZeneca$438
- Regeneron Healthcare Solutions, Inc.$350
- GSK$302
- Novartis$237
- plus $939 from 20 others
Across 4 payments — averaging $26,037 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astrazeneca UK Limited$76K
- Sanofi US Services Inc.$28K
What the payments were for
- Food & beverage$3,20397%
- Education$893%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 17 | $539 |
| Amgen | 15 | $488 |
| AstraZeneca | 20 | $438 |
| Regeneron Healthcare Solutions, Inc. | 11 | $350 |
| GSK | 11 | $302 |
| Novartis | 9 | $237 |
| Genentech USA, Inc. | 5 | $143 |
| Blueprint Medicines Corporation | 5 | $124 |
| Harmony Biosciences LLC | 4 | $90 |
| Grifols USA, LLC | 3 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| Azurity Pharmaceuticals, Inc. | 2 | $49 |
| LEO Pharma Inc. | 2 | $41 |
| Electromed, Inc. | 2 | $39 |
| Covis Pharma GmbH | 2 | $36 |
| Incyte Corporation | 1 | $30 |
| Lilly USA, LLC | 1 | $27 |
| Ventec Life Systems, Inc. | 1 | $26 |
| Advanced Respiratory, Inc | 1 | $26 |
| CSL Behring | 1 | $25 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
| Pharming Healthcare, Inc. | 1 | $23 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| Vertex | 1 | $19 |
| Chiesi USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,293 in reported general payments places this provider in the 80th percentile of 99 pediatric pulmonology providers in California.
Other pediatric pulmonology in Torrance
- Sande OkeloLos Angeles$146K
- Rakesh BhattacharjeeSan Diego$72K
- Carlos MillaPalo Alto$65K
- Terry RobinsonPalo Alto$23K
- Sudhakar ReddivalamMadera$14K
- Marilynn ChanSan Diego$11K
- Lauro RobertoFresno$10K
- John SaitoFountain Valley$8K
- Filomena Hazel VillaMadera$8K
- Richard MossPalo Alto$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.